NCT06919640View on ClinicalTrials.gov

Psilocybin With Intracranial Neural Sensing

PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions

Chronic Pain

Interventions

DRUG

Psilocybin

10mg oral psilocybin

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors

lead

Joshua Woolley, MD, PhD

OTHER